Kerna
7+Portfolio
Focus on early‑stage investments in cutting‑edge therapeutic platform technologies such as genome engineering, cell reprogramming, and computational biology.
Where they invest
Geography
Portfolio footprintHover a country to explore
- United States of America
- 57.1%
- United Kingdom
- 14.3%
- Canada
- 14.3%
Darker countries represent a larger share of the portfolio.
What they back
Industries
- Biotechnology
- 57.1%
- Enterprise Software
- 42.9%
- Artificial Intelligence
- 28.6%
- Data & Analytics
- 14.3%
- Logistics & Supply Chain
- 14.3%
- Financial Technology
- 14.3%
% of all portfolio companies. Industry categories can overlap.
Stages
Stage indicator
No stages listed